In line with earlier findings demonstrating the impact of microbial signals on DNMT3A expression and DNAm signatures in IECs57, our results may help define potential early therapeutic intervention points in individuals at risk for IBD, e.g., by rationale ecobiotherapy aiming to normalize DNAm signatures. The gene discussed is DNMT3A; the disease is inflammatory bowel disease.